Literature DB >> 29152056

Distant metastasis is a critical mode of failure for patients with localized major salivary gland tumors treated with surgery and radiation.

Moses Tam1, Nadeem Riaz1, Lucas Resende Salgado1, Daniel E Spratt1, Evangelia Katsoulakis1, Alan Ho2, Luc G T Morris3, Richard Wong3, Suzanne Wolden1, Shyam Rao1, Nancy Lee1.   

Abstract

OBJECTIVES: Excellent local-regional control can be achieved for major salivary gland tumors treated with surgery and post-operative radiotherapy. We evaluated the cumulative incidence and predictors of distant metastasis in high-risk major salivary gland tumors.
METHODS: Between 1990 and 2011, 200 patients with major salivary gland tumors received post-operative radiotherapy at our center. The patients' median age was 60 years. Patients had primary tumors of the parotid gland (84%), submandibular (16%), and one sublingual gland. Among the patients, 34% had T3-T4 tumors, 32% had nodal involvement. Other high-risk features included close/positive margins and high grade tumors. The median RT dose was 63 Gy.
RESULTS: With a median follow-up of 50 months, the 5-year local control and regional control were 88% and 94%, respectively. The 5-year freedom from distant metastasis was 73%. The median overall survival was 14.6 years corresponding to a 5 and 10-year overall survival of 77% and 59%, respectively. T category and nodal involvement were independent predictors of distant metastasis. Nodal involvement was also an independent predictor of overall survival.
CONCLUSIONS: Distant relapse was the predominant mode of failure despite excellent local-regional control in high-risk major salivary gland tumors. Both advanced T category and nodal involvement were independent predictors of distant metastasis. More effective systemic therapy is needed to combat distant relapse.

Entities:  

Keywords:  distant metastasis; major salivary gland tumors; parotid gland; radiation therapy; systemic therapy

Year:  2013        PMID: 29152056      PMCID: PMC5687575          DOI: 10.1007/s13566-013-0107-6

Source DB:  PubMed          Journal:  J Radiat Oncol        ISSN: 1948-7908


  20 in total

1.  Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.

Authors:  Jonathan D Schoenfeld; David J Sher; Charles M Norris; Robert I Haddad; Marshall R Posner; Tracy A Balboni; Roy B Tishler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-13       Impact factor: 7.038

2.  Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors.

Authors:  Usama Mahmood; Matthew Koshy; Olga Goloubeva; Mohan Suntharalingam
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-10

3.  Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.

Authors:  Trevor M Feinstein; Stephen Y Lai; Diana Lenzner; William Gooding; Robert L Ferris; Jennifer R Grandis; Eugene N Myers; Jonas T Johnson; Dwight E Heron; Athanassios Argiris
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

4.  Radiotherapy alone or combined with surgery for salivary gland carcinoma.

Authors:  William M Mendenhall; Christopher G Morris; Robert J Amdur; John W Werning; Douglas B Villaret
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

5.  Prognostic factors in major salivary gland cancer.

Authors:  E Hocwald; H Korkmaz; G H Yoo; V Adsay; T Y Shibuya; J Abrams; J R Jacobs
Journal:  Laryngoscope       Date:  2001-08       Impact factor: 3.325

6.  Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.

Authors:  Aaron W Pederson; Joseph K Salama; Daniel J Haraf; Mary Ellen Witt; Kerstin M Stenson; Louis Portugal; Tanguy Seiwert; Victoria M Villaflor; Ezra E W Cohen; Everett E Vokes; Elizabeth A Blair
Journal:  Head Neck Oncol       Date:  2011-07-26

Review 7.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

8.  Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy.

Authors:  Jae Myoung Noh; Yong Chan Ahn; Heerim Nam; Won Park; Chung-Hwan Baek; Young-Ik Son; Han-Sin Jeong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-06-30       Impact factor: 3.372

9.  Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.

Authors:  Tawee Tanvetyanon; Dahui Qin; Tapan Padhya; Judith McCaffrey; Weiwei Zhu; David Boulware; Ronald DeConti; Andy Trotti
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-07

10.  Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy.

Authors:  J G Armstrong; L B Harrison; R H Spiro; D E Fass; E W Strong; Z Y Fuks
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03
View more
  1 in total

1.  Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy.

Authors:  Kaveh Zakeri; Huili Wang; Jung Julie Kang; Anna Lee; Paul Romesser; Nader Mohamed; Daphna Gelblum; Eric Sherman; Lara Dunn; Jay Boyle; Richard Wong; Linda Chen; Yao Yu; C Jillian Tsai; Sean M McBride; Nadeem Riaz; Nancy Lee
Journal:  Head Neck       Date:  2021-02-19       Impact factor: 3.821

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.